Navigation Links
Nopras Technologies, Inc. Achieves ISO 9001:2008 Certification
Date:1/10/2011

NOVI, Mich., Jan. 10, 2011 /PRNewswire/ -- Nopras Technologies, Inc., a globally recognized management consulting firm which specializes in services for organizations in the Pharmaceutical, Biotechnology, Medical Device and other FDA regulated industries announced on January 10th, 2011 that it has achieved ISO 9001:2008 certification.

Nopras Technologies' well documented procedures and processes, its proactive response, commitment to quality and focus on customer satisfaction and continual improvements were highly appreciated by the auditor from the certifying body. "The certification is a testimony to the fact that the services rendered by Nopras Technologies, Inc. are in conformity with international quality standards," states Alliance International Registrar, LLC.

"We are proud to have completed and attained ISO 9001:2008 certification," states Carla Glaze, Nopras Technologies' President. "This certification is a testament to Nopras' risk-based Quality Management System approach that provides the framework to ensure that we meet or exceed our customer's expectations. Our Quality Management Program includes formalized procedures that address Project Management and Quality Control of field operations."

Nopras Technologies supports its quality management system by performing periodic internal audits, comprehensive training, and preventive and corrective activities, as necessary. ISO 9001:2008 is an international quality management standard and framework focused on enhancing customer satisfaction, assuring conformity to statutory and regulatory requirements and continual improvement of business performance.

About Nopras Technologies, Inc.

Nopras Technologies, Inc. is a management consulting firm providing regulatory consulting services to the global pharmaceutical, biologics/biotechnology and medical device industries. Nopras Technologies' provides a broad spectrum of Regulatory, Compliance and Quality Services, Operational Improvement and Technical Services, Turnkey Solutions Services (Facility Start-Up and New Product Launch).

Its service portfolio covers FDA and foreign regulations/ guidelines and spans the full product development life cycle; from clinical development through market scrutiny.

The firm's staff consists of well-credentialed scientists, engineers, physicians and technical experts from industry leaders with extensive business and industry experience; many of whom are key opinion leaders, have held key management positions and have earned advanced degrees in medicine, science, engineering and business operate as a working team to integrate the different skill sets they offer. The company is based in Novi, MI with offices in Fort Washington, PA and Singapore. For more information, visit www.nopras-tech.com.


'/>"/>
SOURCE Nopras Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novo Nordisk A/S and Emisphere Technologies, Inc. Announce License Agreement to Develop Oral Formulation of Insulin for Diabetes
2. China Medical Technologies, Inc. Announces the Closing of US$150 Million Convertible Senior Note Offering and the Completion of Repurchase of US$105.9 Million Convertible Notes Due 2011
3. Reportlinker Adds Proteomics - Technologies, Markets and Companies
4. The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion
5. Medical Device Industry Executive Joins OrthoAccel Technologies, Inc. Board of Directors
6. All-Time High in Q Orders for Wound Management Technologies, Inc.
7. Wound Management Technologies, Inc. Furthers its Government Initiatives and Business Development within the Veterans Health Administration
8. Reportlinker Adds Cell Therapy - Technologies, Markets and Companies
9. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
10. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
11. Mark S. Rangell Appointed Chief Operating Officer for Sandata Technologies, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
(Date:5/3/2016)... KANSAS CITY, Mo. , May 3, 2016 ... of Kansas Medical Center,s Institute for Advancing Medical ... develop and commercialize new drugs, diagnostics and medical ... organizations provides BioNovus Innovations with rights to license, ... "This partnership ...
(Date:5/3/2016)... ACME Markets, Delaware County ... Councilman Dave White announced today the availability ... pharmacies across Delaware County . According ... has saved 26,463 lives nationwide over the past 20 years. Since ... were authorized to administer naloxone to overdose victims, 244 lives ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... 05, 2016 , ... TLC Laser Eye Centers announced today that it has ... will now be called “Gordon Schanzlin New Vision Institute, a TLC Laser Eye Center.” ... facility to ensure that patients continue to receive the highest quality of care. In ...
(Date:5/5/2016)... (PRWEB) , ... May 05, ... ... and hands-on exercises, the Wharton Seminars for Business Journalists , led ... understanding of key business and economic issues.  This one-day program at the ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... and Make-A-Wish grants the most heartfelt wishes of these children. The wishes ... medical treatment. President and CEO of Make-A-Wish Mississippi, Brent Wilson said, “In ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... A recent ... continue to face challenges in getting employees to understand and use the free preventive ... of the nation’s leading non-profit business groups of large, self-insured public and private employers, ...
(Date:5/5/2016)... Pittsburgh, PA (PRWEB) , ... May 05, 2016 ... ... risk factors among Pittsburgh-area schoolchildren has found that more than 40 percent of ... Deborah Gentile, MD , Director of Allergy and Asthma Clinical Research in the ...
Breaking Medicine News(10 mins):